Phase 2 Randomized, Open-Label Study of Gs-5885 Administered Concomitantly with Gs-9451, Tegobuvir and Ribavirin...... Grant uri icon

Overview

total award amount

  • 16992.18
  • 22045.18
  • 4600.00

sponsor award id

  • GS-US-248-0120

Background

Time

date/time interval

  • June 20, 2011 - June 7, 2012
  • June 20, 2011 - June 7, 2012
  • June 20, 2011 - June 7, 2013

Identity

DSR Number

  • 11071123
  • 11112054
  • 11121156
  • 12012945
  • 12020769
  • 12031846
  • 12033146
  • 12042447
  • 12080254

PeopleSoft Contract Number

  • 00081951